Product Program year 2023 Source: CMS Open Payments

Endotine

Device Aesthetics

Open in the dashboard

General payments

$90,078

46 payments

Research payments

$0

0 payments

Through program year 2023, $90,078 in general payments and $0 in research payments were reported against Endotine (Aesthetics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2023 General $37,768 20
2022 General $27,336 17
2021 General $24,974 9

Breakdown

Who paid General payments · program years 2021–2023
  1. MicroAire Surgical Instruments LLC $90,078 46 payments
Top recipients General payments · program year 2023
  1. Theodore Diktaban Plastic and Reconstructive Surgery · New York, NY $19,937 53% · 14 payments
  2. David Shaffer Flushing, NY $9,000 24% · 2 payments
  3. John Zimmermann Napa, CA $8,831 23% · 4 payments

Each share is of general payments naming this product in 2023.

Specialties paid General payments · program year 2023
  1. Plastic and Reconstructive Surgery Surgery $19,937 100% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2023
  1. New York $28,937 77% · 2 recipients
  2. California $8,831 23% · 1 recipient

Each share is of general payments naming this product in 2023 where a state was reported.

46 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record